Cross-Sector entity
All 1 tracked stories fall under one category: pharma. Caldolor is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. VIBATIV appears in 1 tracked Cross-Sector story from March 5, 2026. The tracked stories average 2 original sources each.
1 verified story tracked
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Caldolor is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. VIBATIV appears in 1 tracked Cross-Sector story from March 5, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering VIBATIV. Shared-story counts are live from our verified record — not editorial picks.
Rigel Pharmaceuticals and Cumberland Pharmaceuticals reported Q4 results that emphasize commercial execution and a shift toward sustainable profitability. Both companies are leveraging core hospital and oncology assets to navigate a market that increasingly rewards revenue-generating biotechs over speculative R&D.
